There is growing evidence for the role of voltage-gated L-type Ca2+ channels in mediating aspects of the addictive properties of psychostimulants. L-type Ca2+ channels activate Ca2+ second-messenger pathways that regulate protein phosphorylation and thereby activation of target gene expression. Here the authors will review recent progress in our understanding of L-type Ca2+ channel-activated signal transduction pathways that contribute to molecular neuroadaptations evident following acute and chronic exposures to psychostimulants.
Berke JD, Hyman SE. 2000. Addiction, dopamine, and the molecular mechanisms of memory. Neuron25:515-532.
2.
Bhalla US, Ram PT, Iyengar R.2002. MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science297:1018-1023.
3.
Bonci A, Bernardi G, Grillner P, Mercuri NB. 2003. The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction?Trends Pharmacol Sci24:172-177.
4.
Caporaso GL, Bibb JA, Snyder GL, Valle C, Rakhilin S, Fienberg AA, and others. 2000. Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia. Neuropharmacology39:1637-1644.
5.
Carlezon WA Jr, Nestler EJ. 2002. Elevated levels of GluR1 in the mid-brain: a trigger for sensitization to drugs of abuse?Trends Neurosci25:610-615.
6.
Catterall WA. 1988. Structure and function of voltage-sensitive ion channels. Science242:50-61.
7.
Chang KT, Berg DK. 2001. Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons. Neuron32:855-865.
8.
Craven SE, Bredt DS. 1998. PDZ proteins organize synaptic signaling pathways. Cell93:495-498.
9.
Davare MA, Dong F, Rubin CS, Hell JW. 1999. The A-kinase anchor protein MAP2B and cAMP-dependent protein kinase are associated with class C L-type calcium channels in neurons. J Biol Chem274:30280-30287.
10.
Davare MA, Horne MC, Hell JW. 2000. Protein phosphatase 2A is associated with class C L-type calcium channels (Cav1.2) and antagonizes channel phosphorylation by cAMP-dependent protein kinase. J Biol Chem275:39710-39717.
11.
Deisseroth K, Mermelstein PG, Xia H, Tsien RW. 2003. Signaling from synapse to nucleus: the logic behind the mechanisms. Curr Opin Neurobiol13:354-365.
12.
Dolmetsch RE, Pajvani U, Fife K, Spotts JM, Greenberg ME. 2001. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science294:333-339.
13.
Ertel EA, Campbell KP, Harpold MM, Hofmann F, Mori Y, Perez-Reyes E, and others. 2000. Nomenclature of voltage-gated calcium channels. Neuron25:533-535.
14.
Everitt BJ, Wolf ME. 2002. Psychomotor stimulant addiction: a neural systems perspective. J Neurosci22:3312-3320.
15.
Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM. 2003. It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci26:184-192.
16.
Graef IA, Mermelstein PG, Stankunas K, Neilson JR, Deisseroth K, Tsien RW, and others. 1999. L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons. Nature401:703-708.
17.
Greengard P.2001. The neurobiology of slow synaptic transmission. Science294:1024-1030.
18.
Groth RD, Dunbar RL, Mermelstein PG. 2003. Calcineurin regulation of neuronal plasticity. Biochem Biophys Res Commun311:1159-1171.
19.
Hell JW, Westenbroek RE, Warner C, Ahlijanian MK, Prystay W, Gilbert MM, and others. 1993. Identification and differential sub-cellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits. J Cell Biol123:949-962.
20.
Hernandez-Lopez S, Tkatch T, Perez-Garci E, Galarraga E, Bargas J, Hamm H, and others. 2000. D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade. J Neurosci20:8987-8995.
21.
Hyman SE, Malenka RC. 2001. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci2:695-703.
22.
Karler R, Calder LD, Chaudhry IA, Turkanis SA. 1989. Blockade of “reverse tolerance” to cocaine and amphetamine by MK-801. Life Sci45:599-606.
23.
Karler R, Turkanis SA, Partlow LM, Calder LD. 1991. Calcium channel blockers and behavioral sensitization. Life Sci49:165-170.
24.
Koschak A, Reimer D, Huber I, Grabner M, Glossmann H, Engel J, and others. 2001. alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages. J Biol Chem276: 22100-22106.
25.
Kurschner C, Mermelstein PG, Holden WT, Surmeier DJ. 1998. CIPP, a novel multivalent PDZ domain protein, selectively interacts with Kir4.0 family members, NMDA receptor subunits, neurexins, and neuroligins. Mol Cell Neurosci11:161-172.
26.
Kurschner C, Yuzaki M.1999. Neuronal interleukin-16 (NIL-16): a dual function PDZ domain protein. J Neurosci19:7770-7780.
27.
Licata SC, Pierce RC. 2003. The roles of calcium/calmodulin-dependent and Ras/mitogen-activated protein kinases in the development of psychostimulant-induced behavioral sensitization. J Neurochem85:14-22.
28.
Lipscombe D.2002. L-type calcium channels: highs and new lows. Circ Res90:933-935.
29.
Liu FC, Graybiel AM. 1996. Spatiotemporal dynamics of CREB phosphorylation: transient versus sustained phosphorylation in the developing striatum. Neuron17:1133-1144.
30.
Liu L, Fan QI, El-Zaru MR, Vanderpool K, Hines RN, Marsh JD. 2000. Regulation of DHP receptor expression by elements in the 5’-flanking sequence. Am J Physiol Heart Circ Physiol278: H1153-H1162.
31.
Michelhaugh SK, Gnegy ME. 2000. Differential regulation of calmodulin content and calmodulin messenger RNA levels by acute and repeated, intermittent amphetamine in dopaminergic terminal and midbrain areas. Neuroscience98:275-285.
Olson PA, Tkatch T, Hernandez-Lopez S, Ulrich S, Ilijic E, Mugnaini E, and others. 2005. G-protein-coupled receptor modulation of striatal CaV1.3 L-type Ca2+ channels is dependent on a Shank-binding domain. J Neurosci25:1050-1062.
34.
Pierce RC, Pierce-Bancroft AF, Prasad BM. 1999. Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/Mitogen-activated protein kinase signal transduction cascade. J Neurosci19:8685-8695.
35.
Pierce RC, Quick EA, Reeder DC, Morgan ZR, Kalivas PW. 1998. Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther286:1171-1176.
36.
Platzer J, Engel J, Schrott-Fischer A, Stephan K, Bova S, Chen H, and others. 2000. Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell102:89-97.
37.
Rajadhyaksha A, Barczak A, Macias W, Leveque JC, Lewis SE, Konradi C.1999. L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons. J Neurosci19:6348-6359.
38.
Rajadhyaksha A, Husson I, Satpute SS, Kuppenbender KD, Ren JQ, Guerriero RM, and others. 2004. L-type Ca2+ channels mediate adaptation of extracellular signal-regulated kinase 1/2 phosphorylation in the ventral tegmental area after chronic amphetamine treatment. J Neurosci24:7464-7476.
39.
Rakhilin SV, Olson PA, Nishi A, Starkova NN, Fienberg AA, Nairn AC, and others. 2004. A network of control mediated by regulator of calcium/calmodulin-dependent signaling. Science306:698-701.
40.
Scheggi S, Rauggi R, Gambarana C, Tagliamonte A, De Montis MG. 2004. Dopamine and cyclic AMP-regulated phosphoprotein-32 phosphorylation pattern in cocaine and morphine-sensitized rats. J Neurochem90:792-799.
41.
Sheng M, Pak DT. 2000. Ligand-gated ion channel interactions with cytoskeletal and signaling proteins. Annu Rev Physiol62:755-778.
42.
Sinnegger-Brauns MJ, Hetzenauer A, Huber IG, Renstrom E, Wietzorrek G, Berjukov S, and others. 2004. Isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by L-type Ca 2+ channels. J Clin Invest113:1430-1439.
43.
Snyder GL, Galdi S, Fienberg AA, Allen P, Nairn AC, Greengard P.2003. Regulation of AMPA receptor dephosphorylation by glutamate receptor agonists. Neuropharmacology45:703-713.
44.
Sorg BA, Ulibarri C.1995. Application of a protein synthesis inhibitor into the ventral tegmental area, but not the nucleus accumbens, prevents behavioral sensitization to cocaine. Synapse20:217-224.
45.
Surmeier DJ, Bargas J, Hemmings HC Jr, Nairn AC, Greengard P.1995. Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron14:385-397.
46.
Sweatt JD. 2001. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem76:1-10.
47.
Szumlinski KK, Dehoff MH, Kang SH, Frys KA, Lominac KD, Klugmann M, and others. 2004. Homer proteins regulate sensitivity to cocaine. Neuron43:401-413.
48.
Thomas GM, Huganir RL. 2004. MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci5:173-183.
49.
Thomas MJ, Beurrier C, Bonci A, Malenka RC. 2001. Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nat Neurosci4:1217-1223.
50.
Vezina P.2004. Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci Biobehav Rev27:827-839.
51.
Vezina P, Queen AL. 2000. Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area. Psychopharmacology (Berl)151:184-191.
52.
Walker D, De Waard M.1998. Subunit interaction sites in voltage-dependent Ca2+ channels: role in channel function. Trends Neurosci21:148-154.
53.
Wang XB, Uhl GR. 1998. Subtracted differential display: genes with amphetamine-altered expression patterns include calcineurin. Brain Res Mol Brain Res53:344-347.
54.
Weick JP, Groth RD, Isaksen AL, Mermelstein PG. 2003. Interactions with PDZ proteins are required for L-type calcium channels to activate cAMP response element-binding protein-dependent gene expression. J Neurosci23:3446-3456.
55.
Winder DG, Sweatt JD. 2001. Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. Nat Rev Neurosci2:461-474.
56.
Wolf ME. 1998. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol54:679-720.
57.
Wolf ME. 2002. Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways. Mol Intervent2:146-157.
58.
Wong W, Scott JD. 2004. AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol5:959-970.
59.
Xia Z, Storm DR. 2005. The role of calmodulin as a signal integrator for synaptic plasticity. Nat Rev Neurosci6:267-276.
60.
Xu W, Lipscombe D.2001. Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines. J Neurosci21:5944-5951.
61.
Zhang H, Maximov A, Fu Y, Xu F, Tang TS, Tkatch T, and others. 2005. Association of CaV1.3 L-type calcium channels with Shank. J Neurosci25:1037-1049.
62.
Zhang XF, Cooper DC, White FJ. 2002. Repeated cocaine treatment decreases whole-cell calcium current in rat nucleus accumbens neurons. J Pharmacol Exp Ther301:1119-1125.
